Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Polypid Ltd Logo

IZRL Holdings of Polypid (PYPD) - Updated Daily

Lock Icon

Key Statistics

🕵🏼Found In🏷Last Price
IZRL$7.41
⚖️Weighting🧢Market Cap
1.34%$138.99m
🏋🏿‍♂️Weight Rank In IZRL🧮Price to Sales
410
💳ARK Estimated Cost Average🌏Country
🇮🇱Israel
🎫ARK Ownership Percent
2.49%
Description
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics. PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with medications, enables precise delivery of drugs at effective release rates, over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trials for the prevention of sternal and abdominal surgical site infections (SSIs).
Website
www.polypid.com

Research Notes and Commentary for PYPD

No Research Notes Found for PYPD